Supply Chain Intelligence

Quoin Pharmaceuticals, Ltd. Supply Chain

QNRX supply chain intelligence for Quoin Pharmaceuticals, Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

QNRX ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
0Customers
3Debt Items
0Related Chains

Quoin Pharmaceuticals, Ltd. Suppliers

TickerNameConfidenceEvidence
SKINVISIBLE-PHARMACEUTICALS-INC SKINVISIBLE-PHARMACEUTICALS-INC 92% Under which Skinvisible granted us an exclusive royalty-bearing license relating to the production and manufacture of prescription drug products
CONTRACT-MANUFACTURER-OF-THE-DRUG-PRODUCT-FOR-CL CONTRACT-MANUFACTURER-OF-THE-DRUG-PRODUCT-FOR-CL 90% The Company is also dependent on several third party suppliers, in some cases a single source supplier including the contract manufacturer of the drug product for clinical development
CONTRACT-RESEARCH-ORGANIZATION CONTRACT-RESEARCH-ORGANIZATION 90% The Company is also dependent on several third party suppliers, in some cases a single source supplier including the contract research organization managing both of the Company’s current clinical studies
SUPPLIER-OF-THE-ACTIVE-PHARMACEUTICAL-INGREDIENT SUPPLIER-OF-THE-ACTIVE-PHARMACEUTICAL-INGREDIENT 90% The Company is also dependent on several third party suppliers, in some cases a single source supplier including the supplier of the active pharmaceutical ingredient (API)

Quoin Pharmaceuticals, Ltd. Customers

No clients on recordNo downstream customers found in our database for Quoin Pharmaceuticals, Ltd..

Quoin Pharmaceuticals, Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
QNRX-DEBT-11999 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
QNRX-DEBT-11998 Warrants outstanding: 16.13 90% xbrl warrant detail from xbrl 2025-10-14.
QNRX-DEBT Debt stack $2.2M 90% Market cache reports total debt of $2.2M.

Quoin Pharmaceuticals, Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Quoin Pharmaceuticals, Ltd..

Quoin Pharmaceuticals, Ltd. Ownership

HolderNameConfidenceEvidence
QNRX-OWNER-SUMMITTX-CAPITAL-L-P Summittx Capital, L.P. 95% 13F/ownership overlay lists Summittx Capital, L.P.; shares held 64,795; ownership 7.72%; value $415,335; as of 2025-12-31.
QNRX-OWNER-AIGH-CAPITAL-MANAGEMENT-LLC AIGH Capital Management LLC 95% 13F/ownership overlay lists AIGH Capital Management LLC; shares held 49,323; ownership 5.88%; value $316,160; as of 2025-12-31.
QNRX-OWNER-ADAR1-CAPITAL-MANAGEMENT-LLC Adar1 Capital Management, LLC 95% 13F/ownership overlay lists Adar1 Capital Management, LLC ; shares held 58,230; ownership 6.94%; value $373,254; as of 2025-12-31.
QNRX-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC Boothbay Fund Management, LLC 95% 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 59,838; ownership 7.13%; value $383,561; as of 2025-12-31.
QNRX-OWNER-STONEPINE-CAPITAL-MANAGEMENT-LLC Stonepine Capital Management, LLC 95% 13F/ownership overlay lists Stonepine Capital Management, LLC; shares held 78,189; ownership 9.32%; value $501,191; as of 2025-12-31.
QNRX-OWNER-IKARIAN-CAPITAL-LLC Ikarian Capital, LLC 95% 13F/ownership overlay lists Ikarian Capital, LLC; shares held 211,538; ownership 25.21%; value $1.4M; as of 2025-12-31.
QNRX-OWNER-RESOLUTE-CAPITAL-ASSET-PARTNERS-LLC Resolute Capital Asset Partners Llc 95% 13F/ownership overlay lists Resolute Capital Asset Partners Llc; shares held 30,000; ownership 3.58%; value $192,299; as of 2025-12-31.
QNRX-OWNER-MILLENNIUM-MANAGEMENT-LLC Millennium Management Llc 95% 13F/ownership overlay lists Millennium Management Llc; shares held 74,817; ownership 8.92%; value $479,576; as of 2025-12-31.
QNRX-OWNER-ABERDEEN-GROUP-PLC Aberdeen Group plc 95% 13F/ownership overlay lists Aberdeen Group plc; shares held 75,000; ownership 8.94%; value $480,749; as of 2025-12-31.
QNRX-OWNER-WOODLINE-PARTNERS-LP Woodline Partners LP 95% 13F/ownership overlay lists Woodline Partners LP; shares held 79,582; ownership 9.49%; value $510,120; as of 2025-12-31.

Quoin Pharmaceuticals, Ltd. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
View QNRX supply chain intel →

Explore the full interactive supply chain map for Quoin Pharmaceuticals, Ltd..

Open QNRX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map